Search

Your search keyword '"Lophatananon, A."' showing total 1,295 results

Search Constraints

Start Over You searched for: Author "Lophatananon, A." Remove constraint Author: "Lophatananon, A."
1,295 results on '"Lophatananon, A."'

Search Results

1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

2. The efficacy of different biomarkers and endpoints to refine referrals for suspected prostate cancer: the TARGET study (Tiered integrAted tests for eaRly diaGnosis of clinically significant ProstatE Tumours)

4. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

5. Exploring the Relationships between Lifestyle Patterns and Epigenetic Biological Age Measures in Men

6. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24

9. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

10. The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink

12. Common genetic and clinical risk factors: association with fatal prostate cancer in the Cohort of Swedish Men

13. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.

14. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.

15. Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study

17. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

18. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.

19. Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization

20. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

21. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

23. Relevance of the MHC region for breast cancer susceptibility in Asians

24. An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank

25. Two truncating variants in FANCC and breast cancer risk.

26. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

27. Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population

29. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

31. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

32. Exploring the Relationships between Lifestyle Patterns and Epigenetic Biological Age Measures in Men.

33. iHELP: Personalised Health Monitoring and Decision Support Based on Artificial Intelligence and Holistic Health Records.

34. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

35. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

37. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

38. Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians

39. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry

40. Predicting risk of endometrial cancer in asymptomatic women (PRECISION): Model development and external validation.

41. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative

42. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

43. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

44. Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

45. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

46. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

47. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

48. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

49. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

50. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

Catalog

Books, media, physical & digital resources